Grégorio Petrirena

Response assessment in recurrent glioblastoma treated with irinotecan-bevacizumab: comparative analysis of the Macdonald, RECIST, RANO, and RECIST + F criteria

Jaime Gállego Pérez‐Larraya, M. Lahutte, Grégorio Petrirena et al. · Neuro-Oncology · 2012 · 106 citations · Full text

Medicine, Oncology, Radiology +17

Coping strategies and quality of life: a longitudinal study of high-grade glioma patient-caregiver dyads

Karine Baumstarck, Olivier Chinot, Émeline Tabouret et al. · Health and Quality of Life Outcomes · 2018 · 66 citations · Full text

Nursing, Oncology, Cancer Symptom Management +16

Coping with a newly diagnosed high-grade glioma: patient-caregiver dyad effects on quality of life

Karine Baumstarck, Tanguy Leroy, Zeinab Hamidou et al. · Journal of Neuro-Oncology · 2016 · 34 citations

Medicine, Neurology, Oncology +12

Recurrent extraneural sonic hedgehog medulloblastoma exhibiting sustained response to vismodegib and temozolomide monotherapies and inter-metastatic molecular heterogeneity at progression

Grégorio Petrirena, Julien Masliah‐Planchon, Quentin Sala et al. · Oncotarget · 2017 · 32 citations · Full text

Medicine, Oncology, Pharmacology +17

RNU6-1 in circulating exosomes differentiates GBM from non-neoplastic brain lesions and PCNSL but not from brain metastases

Montse Puigdelloses, Marisol González-Huarriz, Marc García-Moure et al. · Neuro-Oncology Advances · 2020 · 18 citations · Full text

Medicine, Molecular Biology, Oncology +17